Pasi A Jänne Selected Research

Pasi A Jänne Research Topics

Disease

179	Neoplasms (Cancer) 12/2023 - 12/2003
175	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 05/2002
90	Lung Neoplasms (Lung Cancer) 12/2023 - 01/2003
27	Disease Progression 12/2023 - 05/2004
22	Adenocarcinoma of Lung 01/2023 - 06/2004
14	Neoplasm Metastasis (Metastasis) 02/2024 - 09/2006
11	Mesothelioma 01/2022 - 11/2004
11	Malignant Mesothelioma 12/2016 - 09/2002
8	Epilepsy (Aura) 01/2019 - 04/2016
6	Carcinoma (Carcinomatosis) 12/2023 - 05/2004
6	Breast Neoplasms (Breast Cancer) 11/2021 - 07/2006
5	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 09/2011
5	Diarrhea 06/2022 - 04/2009
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 12/2003
4	Nausea 01/2021 - 05/2004
4	Leukemia 01/2016 - 04/2009
3	Brain Neoplasms (Brain Tumor) 12/2023 - 03/2005
3	Bites and Stings (Sting) 11/2022 - 01/2022
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2018 - 03/2010
3	Neuroblastoma 10/2018 - 12/2010
3	Circulating Neoplastic Cells 01/2018 - 03/2016
3	Pneumonia (Pneumonitis) 04/2016 - 07/2006
3	Fatigue 06/2013 - 04/2009
3	Neutropenia 01/2013 - 07/2008
3	Adenocarcinoma 06/2012 - 05/2004
3	Carcinogenesis 10/2008 - 10/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 08/2007
2	Stomatitis 06/2022 - 11/2014
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

108	ErbB Receptors (EGF Receptor)IBA 12/2023 - 09/2002
77	Tyrosine Kinase InhibitorsIBA 05/2024 - 05/2005
58	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2021 - 05/2005
43	Gefitinib (Iressa)FDA Link 11/2019 - 05/2004
30	Phosphotransferases (Kinase)IBA 12/2023 - 06/2004
24	osimertinibIBA 12/2023 - 04/2015
20	CrizotinibIBA 01/2021 - 10/2010
18	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 05/2004
18	Anaplastic Lymphoma KinaseIBA 10/2018 - 07/2008
16	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2006
15	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2015
13	PlatinumIBA 12/2023 - 09/2007
13	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2015 - 01/2003
12	Proteins (Proteins, Gene)FDA Link 12/2023 - 04/2009
11	Cisplatin (Platino)FDA LinkGeneric 11/2023 - 11/2004
10	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2022 - 05/2007
9	adagrasibIBA 04/2024 - 01/2020
9	Pemetrexed (MTA)FDA Link 12/2023 - 07/2005
9	Monoclonal AntibodiesIBA 01/2023 - 07/2006
8	Cetuximab (Erbitux)FDA Link 04/2024 - 08/2005
8	Cell-Free Nucleic AcidsIBA 12/2023 - 03/2014
8	LigandsIBA 10/2022 - 10/2005
7	AfatinibIBA 12/2018 - 01/2016
6	trastuzumab deruxtecanIBA 04/2024 - 01/2020
6	Carboplatin (JM8)FDA LinkGeneric 11/2023 - 05/2003
6	Adenosine Triphosphate (ATP)IBA 01/2021 - 12/2009
6	dacomitinibIBA 01/2017 - 12/2007
6	Docetaxel (Taxotere)FDA Link 01/2017 - 05/2002
5	AZD 6244IBA 06/2022 - 03/2012
5	Gemcitabine FDA Link 01/2014 - 11/2004
4	Immunoconjugates (Immunoconjugate)IBA 04/2024 - 01/2020
4	NucleotidesIBA 11/2023 - 09/2012
4	mobocertinibIBA 01/2023 - 01/2021
4	tyrosine receptor (receptor, tyrosine)IBA 01/2022 - 10/2008
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 06/2004
4	neratinibIBA 01/2020 - 06/2006
4	NivolumabIBA 01/2018 - 01/2016
4	TOR Serine-Threonine KinasesIBA 10/2014 - 08/2007
4	Epidermal Growth Factor (EGF)IBA 04/2014 - 10/2005
3	AntigensIBA 01/2023 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
3	human ERBB2 proteinIBA 01/2023 - 01/2021
3	Mitogen-Activated Protein KinasesIBA 10/2021 - 05/2007
3	Trastuzumab (Herceptin)FDA Link 01/2021 - 07/2006
3	Bevacizumab (Avastin)FDA Link 10/2019 - 08/2008
3	Everolimus FDA Link 01/2018 - 08/2007
3	ParaffinIBA 12/2012 - 02/2006
3	Formaldehyde (Formol)FDA Link 12/2012 - 02/2006
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2012 - 09/2010
3	Insulin (Novolin)FDA Link 04/2012 - 09/2009
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2010 - 11/2005
3	AntibodiesIBA 03/2010 - 01/2003
2	patritumab deruxtecanIBA 12/2023 - 01/2022
2	Surface Antigens (Surface Antigen)IBA 01/2023 - 01/2018
2	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2023 - 12/2016
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 01/2021
2	B7-H1 AntigenIBA 01/2022 - 08/2017
2	amivantamab-vmjwIBA 01/2022 - 10/2021
2	Messenger RNA (mRNA)IBA 09/2021 - 01/2016
2	Drug CombinationsIBA 03/2021 - 01/2020
2	Circulating Tumor DNAIBA 01/2021 - 03/2016
2	Cysteine (L-Cysteine)FDA Link 01/2021 - 01/2020
2	Alanine Transaminase (SGPT)IBA 01/2021 - 10/2012

Therapy/Procedure

112	Therapeutics 12/2023 - 05/2004
41	Drug Therapy (Chemotherapy) 12/2023 - 01/2003
9	Radiotherapy 10/2019 - 05/2003
8	Immunotherapy 01/2023 - 01/2016
6	Adjuvant Chemotherapy 10/2019 - 11/2004
3	Chemoradiotherapy 05/2024 - 05/2004
3	Precision Medicine 01/2018 - 03/2012
3	Aftercare (After-Treatment) 06/2014 - 07/2006